Alternative mRNA splicing in cancer immunotherapy

Nature Reviews. Immunology
Luke FrankiwGuideng Li

Abstract

Immunotherapies are yielding effective treatments for several previously untreatable cancers. Still, the identification of suitable antigens specific to the tumour that can be targets for cancer vaccines and T cell therapies is a challenge. Alternative processing of mRNA, a phenomenon that has been shown to alter the proteomic diversity of many cancers, may offer the potential of a broadened target space. Here, we discuss the promise of analysing mRNA processing events in cancer cells, with an emphasis on mRNA splicing, for the identification of potential new targets for cancer immunotherapy. Further, we highlight the challenges that must be overcome for this new avenue to have clinical applicability.

References

Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Jan 17, 1996·Journal of the National Cancer Institute·N P RestifoS A Rosenberg
Mar 22, 1996·Science·D R LeachJ P Allison
Jul 10, 1999·International Journal of Cancer. Journal International Du Cancer·C A AarnoudseP I Schrier
Dec 22, 1999·Immunogenetics·H RammenseeS Stevanović
Jun 5, 2002·Annual Review of Biochemistry·Brenda L Bass
Jan 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elisabeth H SlagerMarieke Griffioen
Jan 15, 1962·Proceedings of the National Academy of Sciences of the United States of America·J F SPEYERS OCHOA
Apr 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elisabeth H SlagerSusanne Osanto
Nov 3, 2004·Cancer Research·Julian P Venables
Feb 21, 2007·Nature Structural & Molecular Biology·Rotem KarniAdrian R Krainer
Sep 20, 2007·Nature Immunology·Peter E Jensen
Feb 5, 2008·Cancer Research·Neil H SegalJames P Allison
Oct 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Rotem KarniAdrian R Krainer
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Auinash KalsotraThomas A Cooper
Jan 30, 2010·Nature·Timothy W Nilsen, Brenton R Graveley
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Cynthia V ClowerAdrian R Krainer
Mar 3, 2010·Annual Review of Biochemistry·Kazuko Nishikura
Nov 9, 2010·Nature Methods·Yarden KatzChristopher B Burge
Dec 15, 2010·PLoS Genetics·Joseph K PickrellJonathan K Pritchard
Feb 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul F RobbinsSteven A Rosenberg
Jun 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Sebastien ApcherRobin Fåhraeus
Sep 13, 2011·Nature·Kenichi YoshidaSeishi Ogawa
Oct 15, 2011·The New England Journal of Medicine·E PapaemmanuilUNKNOWN Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium
Dec 14, 2011·The New England Journal of Medicine·Lili WangCatherine J Wu
Dec 14, 2011·Nature Genetics·Timothy A GraubertMatthew J Walter
Jan 17, 2012·Nature Structural & Molecular Biology·Olga AnczukówAdrian R Krainer
Jun 23, 2012·Nature·Matthew J EllisElaine R Mardis
Jun 23, 2012·Nature·Philip J StephensMichael R Stratton

❮ Previous
Next ❯

Citations

Aug 5, 2020·Proceedings of the National Academy of Sciences of the United States of America·Na LiTariq M Rana
Jun 24, 2020·Nature Reviews. Clinical Oncology·Sebastian P HaenPeter Brossart
Apr 19, 2020·Nature Reviews. Clinical Oncology·Sophie C BonnalJuan Valcárcel
Jul 8, 2020·Nature Methods·Alok V Joglekar, Guideng Li
Jul 13, 2020·Journal of Hematology & Oncology·Hai QinLufeng Zheng
Sep 16, 2020·Nature Reviews. Drug Discovery·Simon J HoggRicky W Johnstone
Sep 17, 2020·Cancers·Anca ApavaloaeiClaude Perreault
Nov 5, 2019·Frontiers in Bioengineering and Biotechnology·Tong MengLiming Cheng
Nov 13, 2020·Nucleic Acids Research·Qin LiShenglin Huang
Dec 3, 2020·Cancer Immunology Research·Edward F FritschCatherine J Wu
Jan 21, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Fabiana Perna
Feb 14, 2021·Biomaterials·Fangmin ChenHaijun Yu
Sep 10, 2020·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Tomasz KolendaKatarzyna Lamperska
Feb 25, 2021·Signal Transduction and Targeted Therapy·Yuanjiao ZhangYe Yang
Mar 13, 2021·Trends in Pharmacological Sciences·Yang PanYi Xing
Jun 21, 2020·Current Cancer Drug Targets·Yue WangHairui Wang
Apr 28, 2020·Biophysical Journal·Mihaela EnculescuStefan Legewie
May 1, 2021·International Journal of Molecular Sciences·Marco Del GiudiceMatteo Cereda
May 1, 2021·Genes·Zhongjing Su, Dongyang Huang
May 4, 2021·The Journal of Clinical Investigation·Timothy P Lippert, Roger A Greenberg
May 13, 2021·Lab on a Chip·Elisabet Rosàs-CanyellesAmy E Herr
May 31, 2021·Current Opinion in Pharmacology·Ernesto GuccioneSlim Mzoughi
May 26, 2021·Scientific Reports·Rebecca F HalperinNicholas J Schork
Jun 11, 2021·Wiley Interdisciplinary Reviews. RNA·Subhashis NatuaSanjeev Shukla
May 21, 2021·Molecular Oncology·Krzysztof PastuszakTomasz Stokowy
Jun 18, 2021·World Journal of Gastroenterology : WJG·Zai-Sheng YeLu-Chuan Chen
May 20, 2021·Briefings in Bioinformatics·Guangyuan LiNathan Salomonis
Nov 19, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Qiu PengQianjin Liao

❮ Previous
Next ❯

Methods Mentioned

BETA
RNA-seq
scRNA-seq

Software Mentioned

LeafCutter
SUPPA
rMATs
kallisto
sleuth
JUM
MISO
MAJIQ
Whippet
SpliceAI

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Respirology : Official Journal of the Asian Pacific Society of Respirology
Antonius StevenBruce W Robinson
Expert Opinion on Drug Safety
Gheath AlatrashElizabeth A Mittendorf
© 2021 Meta ULC. All rights reserved